Incorporation of pseudocapsule presence into a modified Clear Cell Likelihood Score (m-ccLS) was associated with a greater than 11 percent higher AUC in differentiating benign and malignant renal masses on mpMRI, according to a new study.
|Articles|December 20, 2000
Imatron opens offices in Europe and Middle East
Imatron announced it has established a direct sales office in Cologne, Germany, to support sales in Central Europe.The announcement came hard on the heels of the news that the company had sold an electron-beam computed tomography scanner to a medical
Advertisement
Imatron announced it has established a direct sales office in Cologne, Germany, to support sales in Central Europe.
The announcement came hard on the heels of the news that the company had sold an electron-beam computed tomography scanner to a medical center in Ankara, Turkey.
The company will also have an office in Dubai, United Arab Emirates, to cover the Middle East and Africa.
Imatron has been riding a wave of record sales and media attention for its EBCT technology, but the company's stock has been languishing at or below the $2 a share level, joining other Nasdaq companies in the doldrums.
Advertisement
Related to this article
For patients with hepatocellular carcinoma (HCC), perfusion beyond tumor margin on contrast-enhanced ultrasound that exceeds gray-scale ultrasound tumor measurement by 5 mm is associated with a 76 percent higher risk of worse recurrence-free survival, according to newly published research.
In the latest episode of his “Interventional Radiology in Focus” series, Mina Makary, MD, discusses the utility of prostatic artery embolization for treating benign prostatic hyperplasia, key imaging considerations and pertinent technique pearls to help facilitate optimal outcomes.
The AI-powered SwiftSight Body Composition software reportedly provides automated quantification of muscle and adipose tissue after a brief MRI scan.
In the second of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD discuss how to handle disagreements with adjunctive AI in breast imaging, whether to include AI assessments in PACS, and whether patients should pay for the use of adjunctive AI.
Has the barrage of passwords, PINs and authenticator apps gone around the bend to a point where it hampers efficiency and productivity?
Catch up on the top radiology content of the past week.
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Clears MRI-Based AI Software for Body Composition Analysis
2
Study Shows Impact of Key mpMRI Features for Enhancing Assessment of Renal Masses
3
Tumor Margin Marker on Contrast-Enhanced Ultrasound May Predict Worse Outcomes in Patients with HCC
4
Interventional Radiology in Focus: A Closer Look at Prostatic Artery Embolization for Benign Prostatic Hyperplasia
5